CCL2 and cancer: We also described the molecular mechanism of AAM polarization and therapeutic strategies for cancer-promoting AAM macrophages, including CCL2 monoclonal antibodies or CSF1R inhibitors, AAM re-acclimation targeting immune checkpoints, and new strategies to improve the “phagocytic ability” of cells.